Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
USA – Viiv Healthcare, a specialist HIV company majority-owned by GlaxoSmithKline with Pfizer and Japan’s Shionogi as shareholders, has settled a global patent infringement lawsuit with Gilead Sciences. The case…
Read More
USA – The U.S. Food and Drug Administration has approved ViiV Healthcare’s HIV treatment Cabenuva for use every two months, which means patients only need to receive an injectable dose…
Read More
USA – Vir Biotechnology and the Bill & Melinda Gates Foundation have collaborated to develop broadly neutralizing antibodies with a vaccinal effect for HIV treatment and malaria prevention. According to…
Read More
USA – Gilead Sciences, Inc. and Merck have temporarily suspended enrollment in a Phase 2 clinical study evaluating an investigational once-weekly oral combination treatment regimen of islatravir and lenacapavir as…
Read More
USA – ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline (GSK) has agreed to collaborate with Shionogi on the development of ultra-long acting HIV drugs that could…
Read More
UK – ViiV Healthcare, a global specialist HIV that is majorly owned by GlaxoSmithKline plc have announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE…
Read More